How Do We Combat Bogus Medicines in the Age of the COVID-19 Pandemic?

Wubshet Tesfaye; Solomon Abrha; Mahipal Sinnollareddy; Bruce Arnold; Andrew Brown; Cynthia Matthew; Victor Oguoma; Gregory M Peterson; Jackson Thomas

doi:10.4269/ajtmh.20-0903

Back

How Do We Combat Bogus Medicines in the Age of the COVID-19 Pandemic?

Journal article

Open access

Peer reviewed

How Do We Combat Bogus Medicines in the Age of the COVID-19 Pandemic?

Wubshet Tesfaye, Solomon Abrha, Mahipal Sinnollareddy, Bruce Arnold, Andrew Brown, Cynthia Matthew, Victor Oguoma, Gregory M Peterson and Jackson Thomas

American Journal of Tropical Medicine and Hygiene, Vol.103(4), pp.1360-1363

2020

DOI: https://doi.org/10.4269/ajtmh.20-0903

PMID: 32815510

Appears in COVID-19 Research

Files and links (1)

pdf

How Do We Combat Bogus Medicines in the Age of the COVID-19 Pandemic84.12 kBDownload View

Published VersionCC BY V4.0, Open Access

Abstract

COVID-19

health governance

health infrastructure

falsified products

The COVID-19 pandemic has brought concurrent challenges. The increased incidence of fake and falsified product distribution is one of these problems with tremendous impact, especially in low- and middle-income countries. Up to a tenth of medicines including antibiotics and antimalarial drugs in the African market are considered falsified. Pandemics make this worse by creating an ecosystem of confusion, distraction, and vulnerability stemming from the pandemic as health systems become more stressed and the workload of individuals increased. These environmentscreate opportunities for substandard and falsified medicines to be more easily introduced into the marketplace by unscrupulous operators. In this work we discuss some of the challenges with fake or falsified product distribution in the context of COVID-19 and proposed strategies to best manage this problem.

Details

Title: How Do We Combat Bogus Medicines in the Age of the COVID-19 Pandemic?
Authors: Wubshet Tesfaye - University of Canberra
Solomon Abrha - University of Canberra
Mahipal Sinnollareddy - Therapeutic Goods Administration (Australia, Canberra) -TGA
Bruce Arnold - University of Canberra
Andrew Brown - IntraHealth International
Cynthia Matthew - University of Canberra
Victor Oguoma (Author) - University of Canberra
Gregory M Peterson (Author) - University of Canberra
Jackson Thomas (Corresponding Author) - University of Canberra
Publication details: American Journal of Tropical Medicine and Hygiene, Vol.103(4), pp.1360-1363
Publisher: American Society of Tropical Medicine and Hygiene
Date published: 2020
DOI: 10.4269/ajtmh.20-0903
ISSN: 1476-1645; 0002-9637
PMID: 32815510
Copyright note: Copyright © 2020 by The American Society of Tropical Medicine and Hygiene. This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Organisation Unit: Thompson Institute
Language: English
Record Identifier: 991121851402621
Output Type: Journal article

Metrics

20 Record Views

24 Times Cited - Web of Science

See more details

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration; International collaboration
Web Of Science research areas: Public, Environmental & Occupational Health; Tropical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites